OpenAI launches GPT-Rosalind to accelerate drug discovery and data analysis
NewsBytes | April 17, 2026 7:39 AM CST
Industry reacts as OpenAI pledges safety
The launch has definitely caught the attention of both tech and pharma circles, especially since two Google DeepMind scientists were recognized in 2024 for AlphaFold, an AI system that predicts protein structures.
Some companies, including IQVIA, even saw their stock dip after the news.
OpenAI says GPT-Rosalind comes with built-in safety checks to prevent misuse, including anything risky like biological weapons, while helping researchers tackle tough problems in drug development more efficiently.
READ NEXT
-
कर्पूर के उपाय: धन और स्वास्थ्य के लिए लाभकारी
-
Starmer leadership crisis reignites over Mandelson vetting bombshell: 'It's back on'
-
Prince Harry and Meghan tour LIVE: Final day starts after Harry says he felt 'betrayed'
-
Tuna sandwiches will be ready in 10 minutes if you ditch mayo for 1 fridge staple
-
"Do not wish to witness fighting spirit of Tamil Nadu": MK Stalin warns BJP govt over Delimitation Bill
